Glenmark Pharmaceuticals unlocks the treatment for mild to moderate Covid-19 in India
MUMBAI: In a landmark development for COVID-19 patients in India, Glenmark Pharmaceuticals announced the launch of antiviral drug Favipiravir (brand name FabiFlu) for the treatment...
Glenmark gets regulator’s approval to try Favipiravir on COVID-19 patients in India
MUMBAI: Glenmark Pharmaceuticals, a research-led pharmaceutical company, announced that it has received approval from the DCGI (Drug Controller General of India), the regulator in India...
Hikma and Glenmark sign agreement to commercialise Ryaltris
LONDON: Hikma Pharmaceuticals and Glenmark Specialty, a Swiss subsidiary of Glenmark Pharmaceuticals, announced the signing of an exclusive US license agreement to commercialise Ryaltris (olopatadine...
Glenmark Pharmaceuticals receives ANDA approval for Clobetasol Propionate Foam
MUMBAI, INDIA: Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Clobetasol Propionate Foam,...